E2F1 and non-small cell lung carcinoma: Furthermore, we knocked down E2F1 in PTTG3P-overexpressing NSCLC cells, and the results showed that E2F1 knockdown could significantly inhibit the PTTG3P overexpression-induced NSCLC cell growth acceleration and migration increase.